Jeremy T. Larsen,MD

MD

Hematologic Oncologist

Jeremy-Larsen-PHX
quotation

I was drawn to Cancer Treatment Centers of America® because of the ability to be a part of the multidisciplinary team and personalized model of care.

Location
CTCA Phoenix
14200 West Celebrate Life Way
Goodyear, Arizona 85338
Specialties
Hematologic Oncology
Education
Medical school:

Creighton University School of Medicine, Omaha, NE

Residency: Internal Medicine – Mayo Clinic College of Medicine, Rochester, MN
Fellowship: Hematology/Oncology – Mayo Clinic College of Medicine, Rochester, MN
Certifications

Internal Medicine – American Board of Internal Medicine
Hematology – American Board of Internal Medicine
Medical Oncology – American Board of Internal Medicine

Jeremy Larsen, MD, joined Cancer Treatment Centers of America® (CTCA), Phoenix, in November 2022. A Hematologic Oncologist on the hematologic malignancies team, he is especially excited to support the expansion of the hospital’s bone marrow transplant program, serving an important and unmet need in the Phoenix area. Dr. Larsen comes to CTCA® with extensive experience, not just in the treatment of blood cancers but also in cancer research, particularly in the area of immunotherapy, having presented widely on treatments of relapsed multiple myeloma and related topics and serving as a peer reviewer for Biology of Blood and Bone Marrow Transportation and other medical journals.

“My goal as a physician is to be present with my patients and build relationships with them so I can be a support throughout their cancer journey,” says Dr. Larsen. “I pride myself in communicating with transparency and compassion, meeting my patients in the middle and taking their preferences and goals into account when recommending a treatment plan.”

After receiving his undergraduate and medical degrees from Creighton University (graduating magna cum laude) and the Creighton University School of Medicine (graduating cum laude) in Omaha, Nebraska, Dr. Larsen went on to complete an internal medicine residency then a hematology/oncology fellowship at Mayo Clinic College of Medicine in Rochester, Minnesota, where he also served as Co-Chief Fellow in the Hematology/Oncology program. Triple board certified in internal medicine, hematology, and medical oncology by the American Board of Internal Medicine, Dr. Larsen has enjoyed a highly decorated career in hematologic oncology, serving Mayo Clinic’s medical school, residency and fellowship programs in the education of trainees, leading clinical trials evaluating novel therapies for multiple myeloma, while also serving as the Multiple Myeloma Disease Working Group clinical chair. During his tenure there, he received numerous honors, including consecutive Top Performing Provider Patient Experience Awards and Award for Outstanding Faculty by the Mayo Clinic School of Continuous Professional Development.

Dr. Larsen was initially exposed to the field of medicine by his mother, who was a nurse, but he found his own calling when he discovered the power of combining his love for science with his desire to make an impact on the lives of those in need. He decided on a career in cancer care in his third year of medical school, when he realized the important role oncologists play in the patient’s cancer journey and the impact he could have on patients during a particularly difficult time in their lives.

Outside of CTCA, Dr. Larsen enjoys traveling and spending time with his wife, a cardiologist, and two young children.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.